Cancer Immunotherapy Trials Network   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Seattle WA United States (2007)

Organization Overview

First Clinical Trial
2013
NCT01727076
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cancer Immunotherapy Trials Network